Marty Shkreli????

"There are fast risers outside academia, too. Martin Shkreli, of the hedge fund MSMB Capital, is just 29 but is well-known to investors for his very public battles with MannKind, developer of an inhaled insulin, and Amag Pharmaceuticals. Now he’s starting his own company, Retrophin, that is developing drugs for rare diseases."

http://www.forbes.com/sites/matthewherper/2012/11/12/who-are-the-young-rising-stars-in-science-and-health-you-tell-us/